Skip to main content

ADVERTISEMENT

Julie Gould

Conference Coverage
08/17/2023
During Specialty Pharmacy Next 2023, Autumn Zuckerman, PharmD, director of Health Outcomes and Research at Vanderbilt Specialty Pharmacy, told the audience about different data types that specialty pharmacies can use and how they relate to...
During Specialty Pharmacy Next 2023, Autumn Zuckerman, PharmD, director of Health Outcomes and Research at Vanderbilt Specialty Pharmacy, told the audience about different data types that specialty pharmacies can use and how they relate to...
During Specialty Pharmacy Next...
08/17/2023
Pharmacy Learning Network
News
08/17/2023
A recent retrospective study shed light on the early challenges faced by United States veterans diagnosed with schizophrenia.
A recent retrospective study shed light on the early challenges faced by United States veterans diagnosed with schizophrenia.
A recent retrospective study...
08/17/2023
Veterans Health Today
Conference Coverage
08/17/2023
Danielle Roman, PharmD, Allegheny Health Network Cancer Institute, recently presented at the 2023 Specialty Pharmacy Next meeting and provided updates in the treatment of breast cancer.
Danielle Roman, PharmD, Allegheny Health Network Cancer Institute, recently presented at the 2023 Specialty Pharmacy Next meeting and provided updates in the treatment of breast cancer.
Danielle Roman, PharmD,...
08/17/2023
Pharmacy Learning Network
Conference Coverage
08/17/2023
In a session at the 2023 Specialty Pharmacy Next meeting, Val Adams, PharmD, broke down therapeutic improvements in non-small cell lung cancer (NSCLC), identified the current clinical therapy limitations, and also highlighted new approaches...
In a session at the 2023 Specialty Pharmacy Next meeting, Val Adams, PharmD, broke down therapeutic improvements in non-small cell lung cancer (NSCLC), identified the current clinical therapy limitations, and also highlighted new approaches...
In a session at the 2023...
08/17/2023
Pharmacy Learning Network
Conference Coverage
08/17/2023
During a session at Specialty Pharmacy Next 2023, Jorge Garcia, PharmD, assistant vice president, Baptist Health Cancer Care, and Kenneth Komorny, PharmD, vice president, chief pharmacy officer, Moffitt Cancer Center, discussed white and...
During a session at Specialty Pharmacy Next 2023, Jorge Garcia, PharmD, assistant vice president, Baptist Health Cancer Care, and Kenneth Komorny, PharmD, vice president, chief pharmacy officer, Moffitt Cancer Center, discussed white and...
During a session at Specialty...
08/17/2023
Pharmacy Learning Network
News
08/11/2023
This study found that patients with Parkinson disease may be more likely to experience postoperative delirium and have a more complex recovery, with longer hospital stays and higher costs.
This study found that patients with Parkinson disease may be more likely to experience postoperative delirium and have a more complex recovery, with longer hospital stays and higher costs.
This study found that patients...
08/11/2023
Annals of Long-Term Care
News
08/10/2023
“Understanding changes in nursing home resident pain over time would provide a more informed perspective, allowing opportunities to alter the course of illness, plan care, and set priorities,” wrote the study authors.
“Understanding changes in nursing home resident pain over time would provide a more informed perspective, allowing opportunities to alter the course of illness, plan care, and set priorities,” wrote the study authors.
“Understanding changes in...
08/10/2023
Annals of Long-Term Care
News
07/31/2023
Researchers investigated the cost-effectiveness of short-course tuberculosis preventive treatment among people living with HIV/AIDS (PLWHA) and household contacts.
Researchers investigated the cost-effectiveness of short-course tuberculosis preventive treatment among people living with HIV/AIDS (PLWHA) and household contacts.
Researchers investigated the...
07/31/2023
First Report Managed Care
News
07/31/2023
Acalabrutinib monotherapy may be a cost-effective treatment option for Medicare patients with treatment-naïve chronic lymphocytic leukemia, according to recent findings.
Acalabrutinib monotherapy may be a cost-effective treatment option for Medicare patients with treatment-naïve chronic lymphocytic leukemia, according to recent findings.
Acalabrutinib monotherapy may be...
07/31/2023
First Report Managed Care
News
07/20/2023
Among patients with diffuse large B-cell lymphoma, pre-existing depression and anxiety were both associated with worse prognoses, according to recent findings.
Among patients with diffuse large B-cell lymphoma, pre-existing depression and anxiety were both associated with worse prognoses, according to recent findings.
Among patients with diffuse...
07/20/2023
First Report Managed Care